The head of Pfizer said in an interview aired Thursday that people will "likely" need a third dose of his company's Covid-19 vaccine within a year of being fully vaccinated.

Pfizer CEO says third dose of COVID-19 vaccine 'likely' needed within 12 months

EU Commission chief Ursula von der Leyen announced plans on Wednesday for a major contract extension for Covid-19 vaccines with Pfizer stretching to 2023. In a sign of confidence in a company that has been a mainstay of Europe's vaccination drive so far, von der Leyen said the EU will start negotiating to buy 1.

EU looks to buy 1.8 billion doses of Pfizer vaccine through 2023 

As countries all over the globe are racing to vaccinate citizens against the deadly coronavirus, researchers in London are trying a new idea. The University of Oxford has launched a so-called Com-Cov study to assess the benefits of mixing and matching coronavirus vaccines.

UK adds COVID-19 vaccines from two more companies to its 'mix and match' trial

From the killing of Ayman al-Zawahiri, the leader of Al-Qaeda to the Russian invasion of Ukraine that has triggered a global food crisis, there is a lot happening across the world.

Pfizer vaccine not very effective against South African variant: Israeli study

The US National Institute of Health has said that it has begun a study to look at why some people suffered serious allergic reactions shortly after receiving the Pfizer-BioNTech and Moderna COVID-19 vaccines.

US begins study on COVID-19 vaccine side-effects

A new Coronavirus strain has been identified in Israel and a bid to secure more Pfizer vaccines has hit a snag this week over political infighting.

New COVID-19 strain detected in Israel, Pfizer vaccine purchase delayed

American multinational pharmaceutical corporation Pfizer has halted a shipment of 700,000 COVID vaccines scheduled to arrive in Israel on Sunday following the country's failure to pay for the last 2.

Pfizer halts delivery of Covid-19 vaccines to ‘banana republic’ Israel after country fails to pay

BioNTech-Pfizer said that their COVID-19 vaccine showed 100 per cent efficacy against the coronavirus in 12 to 15-year-olds, this comes as the pharma company eye approval for the adolescents to get the jabs before the next school year.

BioNtech-Pfizer say COVID-19 jab 100% effective on 12-15 year olds

Pfizer-BioNTech on Thursday claimed their coronavirus vaccine offers protection at least six months after the second dose and is fully effective against the South African variant that has caused concerns worldwide.

Pfizer says Covid-19 vaccine offers protection for at least six months, effective against South African variant

BioNTECh-Pfizer claimed on Wednesday that their coronavirus vaccine has an efficacy of 100 per cent in the 12 to 15-year-old age group. Phase 3 trials conducted on 2,260 adolescents in the US showed "100 per cent efficacy and robust antibody responses", the pharma giants said in a statement.

BioNTech-Pfizer say their Covid-19 vaccine has 100% efficacy in 12-15 year olds

A US study has found that the COVID-19 vaccines developed by Pfizer and Moderna are 90% effective in preventing COVID-19 infection in a real-world setting.

US study: Pfizer, Moderna 90% effective after 2 doses in real world

American pharmaceutical company Pfizer said it has begun human safety testing of a new pill to treat the coronavirus that could be used at the first sign of illness.

Now, a pill to treat coronavirus; Pfizer begins human trials

Pfizer-BioNTech's coronavirus vaccine has an efficacy of 97 per cent in preventing symptomatic disease, a study based on real-world evidence published on Thursday said.

Pfizer vaccine 97% effective in preventing symptomatic Covid-19 disease: Study

The former US President Donald Trump and his wife Melania Trump had received the coronavirus vaccine during their last days in the White House in January, as per locl reports.

Donald and Melania Trump secretly vaccinated in January: Report

The coronavirus vaccines were being hailed as lifesaver and people had assumed that the inoculation drives will bring immediate relief in the pandemic struggles.

Potential 'fourth surge' of coronavirus possible soon, CDC chief warns

The popular Pfizer-BioNtech vaccine against coronavirus might be a tad less effective on people suffering from obesity, a new study has revealed. A group of Italian researchers have discovered that the healthcare workers who were injected with the Pfizer vaccine, and are obese were not able to produce as many antibodies as the other healthy healthcare workers.

Pfizer coronavirus vaccine may be less effective in obesity: Study

According to a recent study done by a group of Italian researchers has discovered that Pfizer BioNTech vaccine maybe less effective when it comes to people with obesity.

Study: Pfizer COVID-19 jabs less effective on obese people

A single dose of Pfizer-BioNTech's coronavirus vaccine is enough to provide strong protection to those people who have had the deadly virus, two studies from the UK claim.

Pfizer vaccine's single dose provides strong immunity to those who have had Covid-19: Study

Pfizer has become a terror. The U.S. pharma company is reportedly asking for military bases and sovereign assets as guarantee for vaccines. WION's Palki Sharma has the details.

Gravitas: Pfizer's abusive vaccine deals

The first big real-world study of the Pfizer BioNTech vaccine to be independently reviewed now shows that the vaccine is highly effective in preventing COVID-19.

Coronavirus Vaccine: Real world study confirms Pfizer Covid-19 vaccine 94% effective

A massive study involving 1.2 million people published on Wednesday showed that Pfizer-BioNTech's coronavirus vaccine is 94 per cent effective. For the Israeli study, published in the New England Journal of Medicine, nearly 600,000 people received Pfizer's drug and an equal number of people did not receive the shots.

Large study shows Pfizer's coronavirus vaccine 94% effective

While countries like India are sending free vaccines to poorer nations, there are companies like Pfizer which are bullying governments. The US-based company Pfizer is holding governments to ransom, interfering with their legislation, and even demanding military bases as guarantee.

How Pfizer tried to bully Argentina and Brazil in exchange for vaccines

US President Joe Biden has reassured Americans that Covid vaccine shots are safe, and hold the key to beating the coronavirus pandemic. The Democratic president on Friday visited a Pfizer factory manufacturing coronavirus vaccines -- at record speed -- in response to the global health crisis.

Biden reassures Americans Covid vaccines are safe

The first dose of the Pfizer vaccination is 85 per cent effective against coronavirus infection between two and four weeks after inoculation, a study published in the Lancet medical journal has said.

Pfizer first dose 85% effective after 2-4 weeks, study says

pfizer

Pfizer, News on Pfizer, stories on Pfizer, articles on Pfizer, Pfizer stories at Wion, Pfizer news, Pfizer latest news